Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LIFUS For Neurological Disorders

NCT: NCT07417280 · RECRUITING

NCT IDNCT07417280
StatusRECRUITING
Start Date2025-12-02
Completion2040-12-31
SponsorUniversity Health Network, Toronto (OTHER)
First posted
Last updated

Brief Summary

Low intensity focused ultrasound (LIFUS) has the potential to be used as a means of non-invasive neuro-modulation. To this day, the use of LIFUS is under investigation. Studies in healthy subjects have shown that application of LIFUS to the motor region of the brain can mildly decrease neuron excitability in healthy controls. The purpose of the present study is to evaluate the effects of LIFUS on brain tissue excitability in patients with movement disorders in order to elucidate the therapeutic potential of LIFUS.

Frequently Asked Questions

What is LIFUS For Neurological Disorders?

LIFUS For Neurological Disorders is a clinical trial registered under NCT07417280. Current status: RECRUITING.

What is the status of NCT07417280?

The current status of NCT07417280 (LIFUS For Neurological Disorders) is: RECRUITING.

When did LIFUS For Neurological Disorders start?

LIFUS For Neurological Disorders started on 2025-12-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.